Aptevo Therapeutics (APVO) Finished Goods (2015 - 2019)
Aptevo Therapeutics (APVO) posted Finished Goods of $3.7 million for Q4 2019, up 168.75% sequentially from $1.4 million in Q3 2019, and up 446.67% YoY from $675000.0 in Q4 2018.
Aptevo Therapeutics (APVO) Finished Goods (2015 - 2019) Analysis & Trends
Aptevo Therapeutics has reported Finished Goods for 5 years, with the latest figure at $3.7 million in Q4 2019.
- Quarterly Finished Goods rose 446.67% year-over-year to $3.7 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $3.7 million (up 446.67% YoY) and the FY2019 annual result came in at $3.7 million, up 446.67% from the prior year.
- Finished Goods rose to $3.7 million in Q4 2019 per APVO's latest filing, from $1.4 million in the prior quarter.
- Over five years, Finished Goods peaked at $9.1 million in Q4 2015 and troughed at $64000.0 in Q2 2018.
- A 5-year average of $2.8 million and a median of $1.2 million in 2017 frame the typical range for Finished Goods.
- The sharpest annual moves came in 2018 and 2019: Finished Goods tumbled 98.95% in 2018, then jumped 670.31% in 2019.
- Over 5 years, Finished Goods stood at $9.1 million in 2015, then tumbled by 97.83% to $197000.0 in 2016, then surged by 148.73% to $490000.0 in 2017, then soared by 37.76% to $675000.0 in 2018, then soared by 446.67% to $3.7 million in 2019.
- According to Business Quant data, Finished Goods over the past three periods registered $3.7 million, $1.4 million, and $493000.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - |
| 10 | Aptevo Therapeutics | 3.40 Mn | -6.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 3.69 Mn |
| Sep 30, 2019 | 1.37 Mn |
| Jun 30, 2019 | 493,000.00 |
| Mar 31, 2019 | 161,000.00 |
| Dec 31, 2018 | 675,000.00 |
| Sep 30, 2018 | 1.46 Mn |
| Jun 30, 2018 | 64,000.00 |
| Mar 31, 2018 | 576,000.00 |
| Dec 31, 2017 | 490,000.00 |
| Sep 30, 2017 | 940,000.00 |
| Jun 30, 2017 | 6.10 Mn |
| Mar 31, 2017 | 6.27 Mn |
| Dec 31, 2016 | 197,000.00 |
| Sep 30, 2016 | 5.28 Mn |
| Jun 30, 2016 | 7.33 Mn |
| Dec 31, 2015 | 9.07 Mn |